Dextromethorphan (DEX) is an antitussive agent used in many cough and cold medications, and dextrorphan (DOR) is its metabolite. Owing to their similar structures, optimization of the condition for the chromatography approach, which is in common use for determination, is both demanding and time-consuming. This paper describes a methodology that combines excitation-emission matrix fluorescence spectra with second-order calibration, and was applied to simultaneously and directly determine DEX and DOR contents in plasma samples.
Introduction
Dextromethorphan (DEX) is an over-the-counter, highly effective and relatively safe antitussive drug, which is the most commonly used cough medication. At therapeutic dose, DEX is not an addictive drug, and is safe to take. However, at higher dose than therapeutic, DEX has psychoactive properties similar to those of phencyclidine (PCP), so it is abused in addicted people, frequently.
1 DEX, regarded as a "poor man's PCP", has led an increasing number of people to slide into its abuse, especially among adolescents and young adults in recent years. 2 It is generally assumed that the therapeutic activity is due to DEX in combination with its active metabolite, dextrorphan (DOR). DEX is extensively metabolized by a first-pass metabolic effect, resulting in a low concentration level of DEX in plasma, 1 -20 ng mL -1 , typically. 3 At the same time, the level of DOR in plasma is also low due to further demethylation of DOR. 4 On account of their low concentration in plasma, a determination technique of high sensitivity is demanded.
A number of methods for the determination of DEX and its metabolites in various matrices such as plasma, urine and saliva, have been reported. Among these methods, a technique based on chromatography is the most widely used, including high-performance liquid chromatography (HPLC), [5] [6] [7] [8] [9] gas chromatography (GC), [10] [11] [12] and liquid chromatography tandem mass spectrometry (LC-MS/MS). 4, 13 Generally, the chromatographic method can achieve a requested limit of detection; particularly, a method based on LC-MS/MS can give the best limit of detection. Unfortunately, they are not only expensive, but also demand a painful pretreatment for intensive extraction and clean-up procedures, which affect the recoveries, resulting in time-consuming and laborious work. In order to achieve a desired limit of detection and recovery without resorting to an expensive instrument and complicated procedure, fluorescence detection was chosen, which is less expensive and can provide high sensitivity of detection. However, the selectivity of fluorescence detection is not sufficient for the simultaneous determination of DEX and DOR in plasma. Fortunately, the second-order calibration method utilizing "mathematical separation" instead of "physical or chemical separation" was brought forward, and overcame this problem.
In this paper, excitation-emission matrix fluorescence combined with second-order calibration methods based on full-rank parallel factor analysis (FRA-PARAFAC) 14 and parallel factor analysis (PARAFAC) 15, 16 was proposed for the direct quantitative analysis of DEX and DOR in plasma samples, which have demonstrated to be simple, rapid, effective and correct. Besides, the figures of merit (FOM) involving the sensitivity (SEN), selectivity (SEL) and limit of detection (LOD) were investigated; also a statistics method, the t-test, was adopted to test and verify the accuracy of the proposed method.
Theory
Over past few decades, there has been a turning point in second-order calibration in accordance with the advent of a modern hyphenated instrument that can produce matrix data for each sample. Second-order calibration can uniquely decompose a three-way data array stacked with a series of response matrices obtained from each sample under the condition that a free rotational problem is present in the decomposition of the bilinear matrix. With regard to excitation-emission matrix fluorescence, three-way fluorescence response data can be acquired. The trilinear model, 17 which has consistency with Beer's law in chemistry, can be given by: 
According to excitation-emission matrix fluorescence data, here N denotes the number of constituents, referred to as the total number of species that can contribute to fluorescence with components of interest and background as well as uncalibrated interferent(s) taken into consideration. xijk is referred to as the fluorescence intensity of sample k at excitation wavelength i and emission wavelength j; it is the element of X (I × J × K). ain is referred to as the relative excitation intensity of the n constituent at excitation wavelength i, the element (i, n) of the relative excitation spectra matrix, A (I × N). bjn is referred to as the relative emission fluorescence intensity of the n constituent at emission wavelength j, the element (j, n) of a relative emission spectra matrix, B (J × N). ckn is referred to the concentration of the n constituent for the kth sample. The element (k, n) is the relative concentration matrix, C (K × N), and eijk is an element of three-way residual array,
The target functions of different algorithms are distinct, and thus different algorithms show different characteristics. All of the algorithms are not all-powerful. In practice, being aimed at the properties and defects of the data, relevant algorithms were chosen.
Parallel factor analysis (PARAFAC) as one of the most popular algorithms at present has been successfully applied to a great deal of three-way data; however, it is not without shortcomings. PARAFAC is limited in applications because it is slow, sensitive to the number of underlying factor and easily comes into two-factor degeneracy.
Based on PARAFAC, the full-rank parallel factor analysis (FRA-PARAFAC) algorithm utilizes the constrained condition of a column full-rank of matrices, A and B, in the alternating least-squares (ALS) procedure.
Comparatively, a main advantage of the FRA-PARAFAC algorithm is that it is robust to the estimated component number as long as the estimated number is not less than the real chemical component number of the system studied. Furthermore, it is fast in the ALS procedure, and avoids the problem of degeneracy.
Since the results of PARAFAC heavily rely on the estimation of the underlying factors, misestimated underlying factors lead the results of PARAFAC to be erroneous; in the meantime, the FRA-PARAFAC algorithm can give more satisfactory results with a correct estimated component number.
Thus, a factor-determining method, named ADD-ONE-UP, 18 was chosen to estimate the number of underlying factors in the system studied. This factor-determining method decomposes a two-way data set, XI×JK and XJ×KI, which were unfolded from a trilinear data array, X, by SVD from two different directions, obtaining the equation X = USV; also X = UcScVc was defined, where Uc and Vc consist of the first c columns of U and V, respectively; Sc is a diagonal matrix with diagonal elements equal to the first c diagonal elements of S. Xc was folded into a three-way data array, Xc, and was decomposed by PARAFAC with N = c. The residual sum of squares is represented by SSRc. For c = 1, 2, 3,..., the approach of SVD decomposition was repeated until SSRc reached its minimum, or satisfied the following inequalities: SSRc > s Determining the figures of merit is an important requisite for method comparison, such as SEN, SEL 19 and LOD. [20] [21] [22] 
Experimental
Reagents and chemicals Dextromethorphan (DEX) was obtained from the National Institute for the Control of Pharmaceutical and Biological Products (Changsha, China); dextrorphan (DOR) was purchased from Sigma (USA). Stock solutions of DEX (9.2 mg mL -1 ) and DOR (4.2 mg mL -1 ) were dissolved with doubly distilled water in a 100-ml brown volumetric flask, and then stored at 4 C.
Apparatus
An F-4500 fluorescence spectrophotometer (Hitachi, Japan) consisting of a continuous xenon lamp was used to perform fluorescence measurements, utilizing a 1-cm quartz cell. All calculations were implemented in the Matlab environment on a personal computer under the Windows XP operating system. All glassware was rinsed with doubly distilled water before use.
Analytical methodology
Working solutions were obtained from diluting the stock solutions. Simultaneous determinations of DEX and DOR were done in 19 samples. As for the calibration set, the concentration ranges of DEX and DOR were 0 -22.3 nmol mL -1 and 0 -18.5 nmol mL -1 . As for the plasma set, the concentration ranges of DEX and DOR were 2.5 -22.3 nmol mL -1 and 2.1 -18.5 nmol mL -1 . Simultaneous determinations of DEX and DOR in plasma samples were performed by adding an appropriate amount of plasma in the plasma set.
Measurement
All of the spectral surfaces were recorded at excitation wavelengths varying from 212 to 282 nm in 2 nm steps, and emission wavelengths varying from 300 to 357 nm in 3 nm steps with a scanning rate of 2400 nm min -1 . The slit width was 5.0/5.0 nm.
Data array
The effect of Rayleigh and Raman scatterings in all response matrices was roughly compensated just by subtracting the average response matrix of three blank solutions. Thus, a 20 × 36 × 19 data array was assembled.
Results and Discussion
From Fig. 1 , we know that the factor-determining analysis using Fig. 1 (a) and (b) show the SSRs traceable from XI×JK and XJ×KI, respectively.
the ADD-ONE-UP indicates that three factors are necessary, because both SSRs traceable from XI×JK and XJ×KI have a minimum when 3 factors are utilized, denoting a recommended factor number of three, consisting of two target analytes and one natural interferent from the plasma background.
The correlation coefficients of dextromethorphan (DEX) and dextrorphan (DOR) by regressing relative concentrations with actual concentrations are 0.9995 and 0.9993; treated with full-rank parallel factor analysis (FRA-PARAFAC), respectively, 0.9996 and 0.9994, dealt with parallel factor analysis (PARAFAC), respectively. The recoveries of DEX and DOR in plasma samples using full-rank parallel factor analysis (FRA-PARAFAC) and parallel factor analysis (PARAFAC) with an estimated number of factors of 3 are given in Table 1 . Figure 2 shows the actual spectral profiles and the resolved profiles from decomposition of the excitation-emission matrix fluorescence data array obtained for both the calibration and plasma samples by using FRA-PARAFAC (Figs. 2a1 and 2b1) and PARAFAC (Figs. 2a2 and 2b2 ) with a factor number of three (N = 3). The resolved profiles associated with the excitation mode are shown in Fig. 2a , and the resolved profiles associated with the emission mode are shown in Fig. 2b . These normalized excitation and emission spectral profiles were collected from matrices A and B, respectively. As shown in Fig. 2 , the emission peak value of the DEX is at 308 nm, and two excitation maxima exist at 222 and 280 nm. Figure 2b shows that emission peak value of DOR is at 309 nm, and two excitation maxima at 226 and 278 nm. It is obvious that the spectra of DEX and DOR are very similar. Additionally, we can know that the interference from the plasma is intense. Thus, it is to know that the simultaneous determination of DEX and DOR in the plasma samples using a typical fluorescence method is impossible. In this paper, in spite of the similarity of DEX and DOR, and the intense interferent from the plasma background, the resolved spectra is similar to their actual spectrum were obtained. The t-test (a = 0.025) was carried out in order to compare the recoveries of DEX and DOR with the ideal value of 100%; the obtained results are in good agreement. The validity can be checked using RMSEP's formula. Table 2 was constructed for the RMSEP results and the figures of merit, including SEN, SEL and LOD. It is aforementioned that direct fluorescence analysis shows weak selectivity in a complex system. However, one can find that second-order calibration based on FRA-PARAFAC and PARAFAC coupled with excitation-emission matrix fluorescence can increase the selectivity, obtain the lower LOD values, and yield a satisfactory predicted capacity for the simultaneous determination of DEX and DOR contents in plasma samples.
Conclusions
In general, second-order calibration, based on the full-rank parallel factor analysis (FRA-PARAFAC) and the parallel factor analysis (PARAFAC) algorithms, coupled with excitation-emission matrix fluorescence, provides a simple, rapid, and effective method for the simultaneous determination of dextromethorphan (DEX) and dextrorphan (DOR) in plasma samples. Employing "second-order advantage", the proposed methodology utilizes "mathematical separation" instead of "physical or chemical separation" to reduce the pretreatment process. Furthermore, t-tests were introduced for investigating the validity and correctness of the results. The information residing in them indicated that both algorithms could provide accurate results. Hopefully, compared to the existing methods, this approach will shorten the pretreatment time, satisfy the need for non-toxic and non-destructive analysis, and make accurate spectral resolution and concentration prediction to become available. It proved potential to be a practical method for the simultaneous determination of DEX and DOR in plasma samples. 
